CYH NYSE Services-General Medical & Surgical Hospitals, Nec Financials FY2016βFY2025
Community Health Systems Inc had $12.5B of revenue in fiscal 2025, down 1.2% on the year before. Over five years, revenue changed +1.2% a year on average.
Last close Β· Oct 23, 2026
$2.92
0.3%Hi! I read Community Health Systems Incβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β1.2%
No. Sales fell 1.2% last year.
Does it make a profit?
4.1%
A little. It keeps 4.1% of every sale as profit.
Does profit turn into cash?
1.7%
Partly. 1.7% of sales ends up as free cash.
Is debt under control?
5.4x
Heavy. Repaying its debt would take 5.4 years of operating profit.
How healthy are the accounts?
8 / 9
Solid. It passes 8 of 9 health tests.
How is the share priced?
1.6x
One share costs 1.6 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Community Health Systems Inc had $12.5B of revenue in fiscal 2025, down 1.2% on the year before. Over five years, revenue changed +1.2% a year on average. Its operating margin was 11.9%, up 7.6Β pts: of every 100 in sales, about 12 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Community Health Systems Inc made $509M of net profit in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $208M in fiscal 2025, 1.7% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $0.1M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.1M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | William Norris JenningsDirector | Sold | 40,000 | $2.96 | $0.1M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· Community Health Systems Inc owes $10.3B more than it holds in cash, about 5.4 years of operating profit.
Cash, debt and the ratios that show how comfortably Community Health Systems Inc can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $507M | $118M | $38.0M | $37.0M | $260M |
| Debt incl. finance leases | $12.4B | $11.9B | $11.7B | $11.6B | $10.6B |
| Net debt / EBITDA | 6.1x | 8.7x | 8.0x | 11.3x | 5.4x |
| Current ratio | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
| Quick ratio | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
| Total assets | $15.2B | $14.7B | $14.5B | $14.1B | $13.2B |
| Total liabilities | $16.0B | $15.4B | $15.3B | $15.4B | $14.0B |
| Shareholders' equity | β$1.4B | β$1.4B | β$1.4B | β$1.9B | β$1.4B |
| Net debt (β = net cash) | $11.9B | $11.7B | $11.7B | $11.6B | $10.3B |
KIRA Β· Its return on capital was 15.9%: every 100 invested in the business earned about 16 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Community Health Systems Inc passes 8 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 5 / 9 | 5 / 9 | 6 / 9 | 3 / 9 | 7 / 9 | 5 / 9 | 4 / 9 | 8 / 9 |
| Accruals ratio | β13.0% | β16.4% | β6.4% | β6.7% | β10.5% | 2.3% | β1.7% | β2.4% | β7.0% | β0.2% |
| Altman Z'' | 0.31 | β0.64 | β0.26 | β0.25 | 0.31 | 0.27 | β0.08 | 0.03 | β0.37 | 0.28 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $18.4B | $15.4B | $14.2B | $13.2B | $11.8B | $12.4B | $12.2B | $12.5B | $12.6B | $12.5B |
| Gross profit | $15.4B | $12.7B | $11.8B | $11.1B | $9.8B | $10.3B | $10.2B | $10.5B | $10.7B | $10.6B |
| Operating income | β$860M | β$1.9B | $208M | $650M | $1.1B | $1.4B | $821M | $957M | $542M | $1.5B |
| Pretax income | β$1.7B | β$2.8B | β$715M | β$430M | $422M | $499M | $349M | $207M | β$283M | $724M |
| Income tax | β$104M | β$449M | β$11.0M | $160M | β$185M | $131M | $170M | $191M | $79.0M | $48.0M |
| Net income | β$1.7B | β$2.5B | β$788M | β$675M | $511M | $230M | $46.0M | β$133M | β$516M | $509M |
| Diluted EPS | β$15.54 | β$22.00 | β$6.99 | β$5.93 | $4.39 | $1.76 | $0.35 | β$1.02 | β$3.90 | $3.77 |
| Diluted shares | 0.11B | 0.11B | 0.11B | 0.11B | 0.12B | 0.13B | 0.13B | 0.13B | 0.13B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | $1.1B | $773M | $274M | $385M | $2.2B | β$131M | $300M | $210M | $480M | $543M |
| Capital expenditure | $744M | $564M | $527M | $438M | $440M | $469M | $415M | $467M | $360M | $335M |
| Free cash flow | $393M | $209M | β$253M | β$53.0M | $1.7B | β$600M | β$115M | β$257M | $120M | $208M |
| Depreciation and amortization | $1.1B | $861M | $700M | $608M | $558M | $540M | $534M | $505M | $486M | $426M |
| Stock-based compensation | $46.0M | $24.0M | $13.0M | $10.0M | $13.0M | $25.0M | $20.0M | $22.0M | $17.0M | $11.0M |
| Acquisitions | $123M | $6.0M | $26.0M | $13.0M | $1.0M | $3.0M | $9.0M | $38.0M | $25.0M | $1.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $238M | $563M | $196M | $216M | $1.7B | $507M | $118M | $38.0M | $37.0M | $260M |
| Total debt | $15.2B | $13.9B | $13.6B | $13.4B | $12.2B | $12.1B | $11.6B | $11.5B | $11.5B | $10.4B |
| Finance lease liabilities | β | β | β | $113M | $79.0M | $241M | $223M | $216M | $195M | $203M |
| Current assets | $4.7B | $4.1B | $3.5B | $3.4B | $4.5B | $3.5B | $3.1B | $3.2B | $3.3B | $3.2B |
| Current liabilities | $2.9B | $2.4B | $2.4B | $2.3B | $2.8B | $2.4B | $2.2B | $2.1B | $2.3B | $2.2B |
| Property and equipment, net | $8.1B | $7.1B | $6.1B | $5.6B | $5.3B | $5.6B | $5.4B | $5.2B | $4.8B | $4.5B |
| Goodwill | $6.5B | $4.7B | $4.6B | $4.3B | $4.2B | $4.2B | $4.2B | $4.0B | $3.8B | $3.3B |
| Intangible assets | $14.0M | $10.0M | β | β | β | β | $2.0M | $20.0M | $15.0M | $7.0M |
| Total assets | $21.9B | $17.5B | $15.9B | $15.6B | $16.0B | $15.2B | $14.7B | $14.5B | $14.1B | $13.2B |
| Total liabilities | $19.7B | $17.6B | $16.8B | $17.2B | $17.1B | $16.0B | $15.4B | $15.3B | $15.4B | $14.0B |
| Shareholders' equity | $1.6B | β$767M | β$1.5B | β$2.2B | β$1.6B | β$1.4B | β$1.4B | β$1.4B | β$1.9B | β$1.4B |
| Margins | ||||||||||
| Gross margin | 83.7% | 82.6% | 83.4% | 83.7% | 83.3% | 83.5% | 83.8% | 84.0% | 84.6% | 85.1% |
| Operating margin | β4.7% | β12.2% | 1.5% | 4.9% | 9.6% | 11.3% | 6.7% | 7.7% | 4.3% | 11.9% |
| EBITDA margin | 1.3% | β6.6% | 6.4% | 9.5% | 14.3% | 15.7% | 11.1% | 11.7% | 8.1% | 15.3% |
| Net margin | β9.3% | β16.0% | β5.6% | β5.1% | 4.3% | 1.9% | 0.4% | β1.1% | β4.1% | 4.1% |
| FCF margin | 2.1% | 1.4% | β1.8% | β0.4% | 14.7% | β4.9% | β0.9% | β2.1% | 0.9% | 1.7% |
| Returns | ||||||||||
| Return on capital | β4.1% | β11.8% | 1.4% | 4.7% | 12.6% | 10.1% | 5.3% | 6.2% | 4.5% | 15.9% |
| Return on capital employed | β4.5% | β12.4% | 1.5% | 4.9% | 8.5% | 10.9% | 6.6% | 7.8% | 4.6% | 13.5% |
| Return on equity | β106.6% | β580.0% | β | β | β | β | β | β | β | β |
| Return on assets | β7.8% | β12.5% | β4.7% | β4.3% | 3.2% | 1.5% | 0.3% | β0.9% | β3.6% | 3.7% |
| Growth | ||||||||||
| Revenue growth | β | β16.7% | β7.8% | β6.7% | β10.8% | 4.9% | β1.3% | 2.3% | 1.2% | β1.2% |
| Net income growth | β | β | β | β | β | β55.0% | β80.0% | β389.1% | β | β |
| EPS growth | β | β | β | β | β | β59.9% | β80.1% | β391.4% | β | β |
| FCF growth | β | β46.8% | β221.1% | β | β | β134.5% | β | β | β | 73.3% |
| Share count change | β | 0.9% | 0.9% | 0.9% | 2.5% | 12.1% | β0.4% | 0.3% | 1.3% | 2.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 62.5x | β | 14.8x | 10.6x | 6.3x | 6.1x | 8.7x | 8.0x | 11.3x | 5.4x |
| Debt / equity | 9.4x | β | β | β | β | β | β | β | β | β |
| Current ratio | 1.6x | 1.7x | 1.5x | 1.5x | 1.6x | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
| Quick ratio | 1.6x | 1.7x | 1.5x | 1.5x | 1.6x | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.0% | 3.7% | 3.7% | 3.3% | 3.7% | 3.8% | 3.4% | 3.7% | 2.8% | 2.7% |
| Stock comp / revenue | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 5.0 | 5.0 | 6.0 | 3.0 | 7.0 | 5.0 | 4.0 | 8.0 |
| Altman Z'' | 0.3 | β0.6 | β0.3 | β0.3 | 0.3 | 0.3 | β0.1 | 0.0 | β0.4 | 0.3 |
| Accruals ratio | β13.0% | β16.4% | β6.4% | β6.7% | β10.5% | 2.3% | β1.7% | β2.4% | β7.0% | β0.2% |
Source: SEC EDGAR XBRL filings (CIK 0001108109). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
